Read all about it! The latest news from the medical technology experts

IOPvet gets the 'thumbs up' around the world

Ingeneus launches IOPvet device

Further patents issued in key regions for the eyePressure device

Revolutionising high eyePressure detection around Australia - and even in the Antarctic

Patents issued in key regions for the eyeTelehealth Platform

Patent issued for Ingeneus' eyeConnect device in China

Patents issued in the US and China for eyeTelehealth products

World first eyeConnect unveiled at Frankston Hospital

Ingeneus products - Good Design Awards winners

Ingeneus products in Good Design Awards finals

Ingeneus appoints new GM Manufacturing

Ingeneus launches eyePressure device

Ingeneus works with SMART Arm

Ingeneus on the move

Ingeneus develops new remote assessment tool

Medical device treats Ocular Pathologies during Vitreoretinal Surgery

V-Patch Medical Systems: reaching the hearts of the travelling public

Double Success for Ingeneus in Government Program

Ingeneus advocates change to the Therapeutic Goods Administration (TGA)

Ingeneus Exhibits at AusMedtech 2011 Conference

Dynamic enhancement of Ingeneus QMS for medical devices and biomedical applications

Exciting opportunities at BiOS 2011 for Ingeneus

Ingeneus engages with emerging markets

New branding & website under Design Vic Business Immersion program

Ingeneus completes software training with its clients

Ingeneus passes TGA Surveillance Audit

Ingeneus signs licensing agreement for low cost diabetic retinopathy system

Ingeneus launches eyePressure device


Medical device treats Ocular Pathologies during Vitreoretinal Surgery

10th February 2012

Retinal detachment, the separation of the retina from the underlying retinal pigment epithelium, is often a medical emergency. With approximately 3% suffering retinal detachment by the age of 85, speedy referrals and early repair can effectively treat this condition with little or no residual vision loss.

Ingeneus has developed a laser system for the treatment of retinal detachments and tears. This system is capable of intravitreal endophotocoagulation of vascular and structural abnormalities of the retina and choroid. This product has been designed as a standalone device or to be seamlessly integrated with existing vitreo-retinal surgical platforms.

Commercialisation Australia Proof of Concept funding was used in the design and development of this medical technology. This latest addition to Ingeneus’ portfolio of laser products, further showcases our experience in the ophthalmic field.